Investigating how sex differences affect pneumonia after brain injuries
The Role of Sex Dimorphism in Post-TBI Bacterial Pneumonia
This study is looking at how being male or female affects the risk and recovery from bacterial pneumonia after a brain injury, with the goal of finding ways to help patients heal better and avoid complications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10468948 on NIH RePORTER |
What this research studies
This research explores the impact of sex dimorphism on the risk and outcomes of bacterial pneumonia following traumatic brain injury (TBI). It focuses on understanding how the immune response differs between males and females after TBI, particularly looking at the role of specific receptors in the lungs that may influence infection rates and severity. By studying both male and female subjects, the research aims to identify potential therapeutic targets that could improve recovery and reduce complications from pneumonia in TBI patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced a traumatic brain injury, particularly those under the age of 46.
Not a fit: Patients who have not experienced a traumatic brain injury or those with pre-existing severe respiratory conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for preventing pneumonia in patients who have suffered a traumatic brain injury.
How similar studies have performed: Previous research has indicated that sex differences can significantly affect immune responses and outcomes in various conditions, suggesting that this approach may yield valuable insights.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Wagener, Brant M — University of Alabama at Birmingham
- Study coordinator: Wagener, Brant M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.